From: Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds
Compound | Study phase | NCT number | Mechanism | Ref |
---|---|---|---|---|
Oxaliplatin | I/II | NCT04068610 | CT26 were treated with OXP were exposed to pre-apoptotic CRT. The HMGB1 release was observed in cells treated with OXP. Findings indicate that OXP can promote immunogenic lung cancer cell death on LLC cells. OXP induces ICD in glioma cells. OXP exposure led to eIF-2a phosphorylation. | |
Ruthenium complexes | NG* | NCT04577742 | KP1339 could trigger ICD markers in vitro like CRT, ATP, and HMGB1 In colon cancer cell lines, plecstatin-1 was also a Ru (II) arene complex with ICD induction properties by ↑ HSP70/90 | |
copper (I/II) complexes | I | NCT02963051 | ↑ ROS levels resulting in ER stress | [195] |
Iridium (III) complexes | III | NCT00548600 | Bis(2-chloroethyl)-azane moiety in an Ir (III) complex could induce ICD in non-small cell lung cancer | [196] |
gold (I) complexes | NG* | NCT04907422 | The compound Arambula et al. reported is redox-active and induces ICD | [197] |